Zepatier Oral Product
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Kaohsiung Medical University Chung-Ho Memorial Hospital
Overview
Zepatier Oral Product is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Zepatier Oral Product clinical trials
Explore related
Medical disclaimer. This page summarizes research about Zepatier Oral Product for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.